COMMENT

Life sciences professionals prioritise quality over cost for PV automation

 Slow progress for male contraceptive trials

insight

Accelerated approval designations in China

Only two accelerated approval designations have been awarded in China since 2015, despite an increase in other drug designations

insight

Accelerated approval designations in China

Only two accelerated approval designations have been awarded in China since 2015, despite an increase in other drug designations

insight

Europe reports the highest prevalence of chronic cough

comment

Could vaccine hesitancy impact hearing disorders?

Life sciences professionals prioritise quality over cost for PV automation

Slow progress for male contraceptive trials

02/24/2024 17:00:41
  • Home | Drug dealing goes digital 
  • In this issue
  • Contents
  • Syrenis
  • Astrix
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Thermo Fisher Scientific Company Insight
  • Thermo Fisher Scientific
  • Comment
  • Life sciences professionals prioritise quality over cost for PV automation
  • Slow progress for male contraceptive trials
  • Accelerated approval designations in China
  • Mimotopes Company Insight
  • Mimotopes
  • In Depth
  • The dark consequences of supply shortages
  • Digitising the pharma supply chain
  • Covid-19 vaccine pricing varies wildly by country and company 
  • Psychedelics and mental health: the next big thing?
  • Schizophrenia drug landscape: a stagnant field on the cusp of change?
  • Are supercomputers set to transform pharma R&D?
  • BEA Technologies
  • Labcorp
  • In Data
  • North America's AI hiring boom
  • The pharma companies leading the way in artificial intelligence
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
11/18/2021 00:00:00